DHC — Diversified Healthcare Trust stock price, charts and financials

NASDAQ·Real Estate·REIT - Healthcare Facilities·USA

Latest market price

8.80

-0.01-0.11%

Overview Short InterestFilings

DHCQT82Diversified Healthcare Trust·NASDAQ

Overview Short InterestFilings

8.80-0.11%

Loading chart...

Screen all →

LTC-1.11%$38.48 SILA+0.00%$30.36 MPT+1.31%$4.65 MPW+0.00%$5.50 NHI-1.82%$74.56 SBRA+0.24%$20.66 NHPAP-0.34%$23.25 NHPBP-0.48%$22.62

Snapshot

Index	-	P/E	-	EPS (ttm)	-1.33	Insider Own	27.55%	Shs Outstand	242.11M	Perf Week	-4.66%

Market Cap	2.13B	Forward P/E	-	EPS next Y	-0.44	Insider Trans	-	Shs Float	186.78M	Perf Month	-3.08%

Enterprise Value	4.43B	PEG	-	EPS next Q	-	Inst Own	-	Short Float	6.70%	Perf Quarter	13.40%

Income	-320.00M	P/S	1.40	EPS this Y	54.70%	Inst Trans	-	Short Ratio	7.31	Perf Half Y	50.68%

Sales	1.52B	P/B	1.32	EPS next Y	26.56%	ROA	-7.50%	Short Interest	12.51M	Perf YTD	81.44%

Book/sh	6.69	P/C	17.46	EPS next 5Y	-	ROE	-18.75%	52W High	9.66 -8.90%	Perf Year	169.11%

Cash/sh	0.50	P/FCF	-	EPS past 3/5Y	-	ROIC	-26.85%	52W Low	3.24 171.60%	Perf 3Y	323.08%

Dividend Est.	0.04 (0.45%)	EV/EBITDA	27.32	Sales past 3/5Y	6.20% -1.18%	Gross Margin	2.11%	Volatility	5.24% 3.70%	Perf 5Y	121.11%

Dividend TTM	0.04 (0.45%)	EV/Sales	2.92	EPS Y/Y TTM	14.19%	Oper. Margin	-2.50%	ATR (14)	0.37	Perf 10Y	-59.54%

Dividend Ex-Date	Jul 20, 2026	Quick Ratio	113.17	Sales Y/Y TTM	1.54%	Profit Margin	-21.10%	RSI (14)	43.64	Recom	2.94

Dividend Gr. 3/5Y	0.00% -25.98%	Current Ratio	113.17	EPS Q/Q	-400.00%	SMA20	-2.99%	Beta	2.23	Target Price	9.25

Payout	-3.02%	Debt/Eq	1.45	Sales Q/Q	-5.43%	SMA50	-1.79%	Rel Volume	2.58	Prev Close	8.81

Employees	600	LT Debt/Eq	1.45	Earnings	Nov 02	SMA200	29.74%	Avg Volume	1.77M	Price	8.80

IPO Date	Feb 23, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	-14.89% -3.61%	Net Debt/EBITDA	14.07	Volume	4,570,002	Change	-0.11%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jun-18-26	Reiterated	RBC Capital	Sector Perform	$8.00
Jun-03-26	Reiterated	Maxim Group	Buy	$10 → $11
May-06-26	Reiterated	Maxim Group		$9.50 → $10
Apr-27-26	Initiated	Maxim	Buy	$9.50
Nov-13-25	Upgrade	RBC Capital	Underperform → Sector Perform
Nov-06-24	Reiterated	B.Riley Financial	Buy	$6.00 → $5.00
Aug-05-24	Reiterated	B. Riley Securities	Buy	$6.00
Jan-17-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Jan-07-20	Upgrade	Raymond James	Underperform → Perform
Apr-03-19	Downgrade	RBC Capital	Sector Perform → Underperform

Latest News

Aug-04-26

Aug-04-2612:40PM

Diversified Healthcare Trust (DHC) Q2 2026 Earnings Call Transcriptseekingalpha.com

11:06AM

Diversified Healthcare Trust Q2 Earnings Call Highlightsmarketbeat.com

Aug-03-26

Aug-03-2607:46PM

Diversified Healthcare (DHC) Q2 FFO Top Estimateszacks.com

04:15PM

Diversified Healthcare Trust Announces Second Quarter 2026 Resultsbusinesswire.com

Jul-31-26

Jul-31-2603:57AM

Arrowstreet Capital Limited Partnership Has $15.64 Million Stock Position in Diversified Healthcare Trust $DHCdefenseworld.net

Jul-09-26

Jul-09-2608:00AM

Diversified Healthcare Trust Announces Quarterly Dividend on Common Sharesbusinesswire.com

Jul-06-26

Jul-06-2604:15PM

Diversified Healthcare Trust Second Quarter 2026 Conference Call Scheduled for Tuesday, August 4thbusinesswire.com

Jul-01-26

Jul-01-2601:01PM

Are You Looking for a Top Momentum Pick? Why Diversified Healthcare (DHC) is a Great Choicezacks.com

Jun-18-26

Jun-18-2609:52AM

RBC Capital Maintains Sector Perform on Diversified Healthcare, Raises Price Target to $8Benzinga

Jun-16-26

Jun-16-2607:15AM

Why Your REIT Strategy Is Likely Failing You, And What To Do InsteadSeekingAlpha

Company

Diversified Healthcare Trust (DHC) operates as a real estate investment trust (REIT) specializing in healthcare properties. Its extensive portfolio comprises medical office buildings, life science facilities, senior living communities, and wellness centers located across the United States. DHC's management is provided by an operating subsidiary of The RMR Group Inc., an alternative asset management company headquartered in Newton, Massachusetts.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	1,518	1,538	1,495	1,410	1,284	1,383	1,632	1,040	1,117
Cost of Goods Sold Incl. D&A	1,485	1,783	1,239	1,185	1,109	1,092	1,237	502	452
Gross Profit	32	-245	256	225	174	291	395	538	665
Selling, General and Administrative Excl. Other	37	46	27	26	26	34	31	37	86
Research and Development	0	0	0	0	0	0	0	0	0
Other Operating Expense	33	-252	0	0	240	271	0	0	0
Operating Income	-38	-39	230	199	-91	-14	364	501	580
Interest Expense	233	204	235	192	209	256	201	180	179
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-48	-40	-364	-301	286	451	-296	-403	-107
Net Income Before Taxes	-319	-284	-370	-293	-15	181	-133	-82	293
Income Taxes	3	2	0	0	1	1	1	0	0
Consolidated Net Income	-320	-286	-370	-294	-16	175	-139	-88	287
Net Income From Continuing Operations	-320	-286	-370	-294	-16	180	-134	-83	292
Net Income	-320	-286	-370	-294	-16	175	-139	-88	287
EPS (Recurring)	-1.33	-1.19	-1.55	-1.23	-0.07	0.73	-0.59	-0.37	1.21
EPS (Basic, Before Extraordinaries)	-1.33	-1.19	-1.55	-1.23	-0.07	0.73	-0.59	-0.37	1.21
EPS (Diluted)	-1.33	-1.19	-1.55	-1.23	-0.07	0.73	-0.59	-0.37	1.21
EBITDA	162	182	230	199	428	708	357	494	574
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	4.23	—	—	9.69
Price To Sales Ratio	1.40	0.76	0.37	0.63	0.12	0.53	0.60	1.93	2.50
Gross Margin	2.11	-15.93	17.12	15.96	13.55	21.04	24.20	51.73	59.53
Operating Margin	-2.50	-2.54	15.38	14.11	-7.09	-1.01	22.30	48.17	51.92
Net Margin	-21.08	-18.60	-24.75	-20.85	-1.25	12.65	-8.52	-8.46	25.69
Shares Outstanding	241	240	240	239	238	238	238	238	238
Market Capitalization	2,121	1,164	552	894	154	735	981	2,009	2,789
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PORTNOY ADAM D.	Director	Jun 14 '23	Buy	3.07	2,000,000	6,132,600	23,250,019	Jun 14
PORTNOY ADAM D.	Director	Jun 13 '23	Buy	3.03	1,992,259	6,026,783	21,250,019	Jun 14
PORTNOY ADAM D.	Director	Jun 12 '23	Buy	2.87	2,011,256	5,778,540	19,257,760	Jun 14
PORTNOY ADAM D.	Director	Jun 09 '23	Buy	2.59	1,905,200	4,943,232	17,246,504	Jun 09
PORTNOY ADAM D.	Director	Jun 08 '23	Buy	2.46	1,690,000	4,163,822	15,341,304	Jun 09
PORTNOY ADAM D.	Director	Jun 07 '23	Buy	2.34	2,400,000	5,609,520	13,651,304	Jun 09
PORTNOY ADAM D.	Director	Jun 06 '23	Buy	1.87	1,603,082	2,991,351	11,251,304	Jun 06
PORTNOY ADAM D.	Director	Jun 05 '23	Buy	1.75	2,318,081	4,065,450	9,648,222	Jun 06
PORTNOY ADAM D.	Director	Jun 02 '23	Buy	1.69	1,625,481	2,752,752	7,330,141	Jun 06
PORTNOY ADAM D.	Director	Jun 01 '23	Buy	1.47	1,454,388	2,135,914	5,704,660	Jun 01
PORTNOY ADAM D.	Director	May 31 '23	Buy	1.35	1,065,000	1,436,153	4,250,272	Jun 01
PORTNOY ADAM D.	Director	May 30 '23	Buy	1.21	635,253	771,261	3,185,272	Jun 01
HARRINGTON JOHN L.	Director	May 12 '21	Sale	3.62	19,500	70,530	0	May 12
HARRINGTON JOHN L.	Director	May 07 '21	Sale	3.90	26,500	103,382	19,500	May 10
ZEYTOONJIAN FREDERICK N	Director	Jul 08 '10	Sale	20.72	4,000	82,892	7,500	Jul 09

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.